Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Magee

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2000
Renal thrombotic microangiopathy associated with interferon-alpha treatment of chronic myeloid leukemiaC C Magee, K Abraham, J Farrell, et al.
Clinical Nephrology|December 22, 1999
Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodiesF Brijker, C C Magee, J W Tervaert, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 27, 2000
Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathwaysT H Stadlbauer, M Schaub, C C Magee, et al.
Journal of the American Society of Nephrology : JASN|September 7, 1999
In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptideC C Magee, H Azuma, A Knoflach, et al.
The Journal of Clinical Investigation|March 17, 1999
Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosisB Murphy, C C Magee, S I Alexander, et al.
Transplantation|November 10, 1998
Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptideN C Chowdhury, D V Saborio, M Garrovillo, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2000
Renal thrombotic microangiopathy associated with interferon-alpha treatment of chronic myeloid leukemiaC C Magee, K Abraham, J Farrell, et al.
Clinical Nephrology|December 22, 1999
Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodiesF Brijker, C C Magee, J W Tervaert, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 27, 2000
Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathwaysT H Stadlbauer, M Schaub, C C Magee, et al.
Journal of the American Society of Nephrology : JASN|September 7, 1999
In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptideC C Magee, H Azuma, A Knoflach, et al.
The Journal of Clinical Investigation|March 17, 1999
Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosisB Murphy, C C Magee, S I Alexander, et al.
Transplantation|November 10, 1998
Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptideN C Chowdhury, D V Saborio, M Garrovillo, et al.
Pageof 2